Critical Assessment of a Structure-Based Screening Campaign for IDO1 Inhibitors: Tips and Pitfalls

Area of Science:

• Biochemistry
• Immunology
• Pharmacology

Background:

• Indoleamine 2,3-dioxygenase 1 (IDO1) is crucial in immune regulation and a target for cancer immunotherapy.
• IDO1 exhibits significant structural plasticity, influencing its catalytic activity and ligand interactions.
• This plasticity poses challenges for structure-based drug design of IDO1 inhibitors.

Purpose of the Study:

• To investigate the impact of IDO1's structural plasticity on ligand recognition.
• To identify novel chemical scaffolds for IDO1 ligands using structure-based screening.
• To provide insights into optimizing fragment-based drug discovery campaigns for IDO1.

Main Methods:

• Fragment library screening against three distinct conformations of indoleamine 2,3-dioxygenase 1 (IDO1).
• Utilizing biochemical, structural, and pharmacological data to analyze enzyme behavior.
• Structure-based drug design approaches were employed.

Main Results:

• The study identified potential novel chemical scaffolds for IDO1 ligands.
• Results highlight how IDO1's conformational flexibility can influence screening outcomes.
• The findings offer practical considerations for structure-based screening campaigns.

Conclusions:

• IDO1's structural plasticity is a critical factor in structure-based ligand discovery.
• Employing multiple enzyme conformations can improve the identification of differentiated chemical scaffolds.
• Understanding IDO1 plasticity is key to successful development of novel inhibitors for cancer immunotherapy.